VIVO just filled this.FORM 62-103F3 REQUIRED DISCLOSURE BY AN ELIGIBLE INSTITUTIONAL INVESTOR UNDER SECTION 4.5(d) Item 1 – Identity of the Eligible Institutional Investor 1.1 State the name and address of the eligible institutional investor. MM Asset Management Inc. (“MM Asset”) 161 Bay Street Suite 2240 Toronto, Ontario M5J 2S1 MMCAP International Inc. SPC (“MMCAP”) is an investment fund advised by MM Asset. Item 2 – Security and Reporting Issuer 2.1 State the designation of securities to which this report relates and the name and address of the head office of the issuer of the securities. VIVO Cannabis Inc. (the “Issuer”) 126 Vanluven Road Napanee, Ontario K7R 3L2 This report relates to common shares (“Shares”) in the capital of the Issuer. 2.2 State the designation and number or principal amount of voting or equity securities of the reporting issuer in respect of which the report is being filed and the securityholding percentage of the eligible institutional investor in the class of securities. As at the end of October, 2020, MM Asset, on behalf of MMCAP, exercised control and direction over: (a) an aggregate principal amount of $5,568,000 of 6% convertible debentures that mature on September 15, 2022, which will be convertible into 20,838,323 Shares at a conversion price of $0.2672 per Share; and (b) 13,892,215 common shares purchase warrants (the “Warrants”), each Warrant entitles the holder to purchase an additional Share at the price of $0.2672 per Share until September 15, 2022, representing approximately 9.56% of the outstanding Shares as reported in its prospectus supplement dated October 8, 2020 to the short form base shelf prospectus dated October 2, 2020, calculated on a partially diluted basis. 2 Item 3 – Statement of Eligibility 3.1 MM Asset is eligible to file reports under Part 4 of National Instrument 62-103. DATED this 10th day of November, 2020. MM ASSET MANAGEMENT INC. By: “Hillel Meltz” Hillel Meltz, President